TWC
DRUG

TD Waterhouse Canada’s Bright Minds Biosciences DRUG Stock Holding History

TD Waterhouse Canada’s Portfolio DRUG Stock Details DRUG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33K Buy
+20
New +$1.57K ﹤0.01% 2168

Other funds holding DRUG

New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SCM
Sterling Capital Management Charlotte, North Carolina $5.9B AUM 29.63% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
SIC
SJS Investment Consulting Sylvania, Ohio $919M AUM 23.4% 1-Year Est. Return

TD Waterhouse Canada's DRUG Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Bright Minds Biosciences (DRUG) in Q2 2026: 20 shares worth $1.33K. The stake represents ﹤0.01% of the portfolio and ranks #2168 among its holdings.

8 funds tracked by Wall St. Rank hold DRUG as of Q2 2026.

  • TD Waterhouse Canada held 20 shares of Bright Minds Biosciences worth $1.33K as of Q2 2026.
  • Bright Minds Biosciences was a new TD Waterhouse Canada position in Q2 2026.
  • Bright Minds Biosciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #2168 holding.
  • 8 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.